SSA
CARL

Schonfeld Strategic Advisors’s Carlsmed CARL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Buy
+283,180
New +$3.42M 0.02% 718

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schonfeld Strategic Advisors's CARL Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Carlsmed (CARL) in Q1 2026: 283,180 shares worth $2.56M. The stake represents 0.02% of the portfolio and ranks #718 among its holdings.

66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Schonfeld Strategic Advisors held 283,180 shares of Carlsmed worth $2.56M as of Q1 2026.
  • Carlsmed was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Carlsmed made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #718 holding.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.